Postdoctoral Fellow | Expert in Tumor Immunotherapy
Adviser, Tumor Immunotherapy Committee, Guangdong Clinical Oncology Association
Member, Cancer Chemotherapy Committee, China Anti-Cancer Association
Member, Hematologic Translational Medicine Committee, China Anti-Cancer Association
Vice Chair, Cancer Prevention & Rehabilitation Committee, Guangdong Health Care Association
Vice Chair, Lymphoma Prevention & Control Committee, Fujian Preventive Medical Association
Expertise：Trained at the Lu Daopei Institute of Hematology, Beijing Medical University (now Peking University Health Science Center). After graduation he completed post-doctoral training at Massachusetts General Hospital, Harvard Medical School, and subsequently joined the MGH faculty. Passed the United States Medical Licensing Examination and obtained U.S. physician certification. Has remained at the clinical forefront for 40 years, focusing on immunotherapy research and treatment of solid tumors, hematologic malignancies, and lymphomas. Received the Leukemia Research Outstanding Contribution Award while in the United States.
